Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons.
• Microglia are the resident immune cells of the central nervous system and play a role in neuroinflammation.

Purpose of the Study:

• To investigate the temporal dynamics of microglial activation in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
• To determine the relationship between microglial activation and dopaminergic neurodegeneration in this model.

Main Methods:

• Mice were administered MPTP to induce Parkinson's disease-like pathology.
• Microglial activation was assessed using Griffonia simplicifolia lectin (GSA-I-B4) staining for cell number and morphology.
• Dopaminergic neurons were identified and quantified using tyrosine hydroxylase (TH) immunohistochemistry.

Main Results:

• MPTP intoxication led to a significant increase in microglial cell number and morphological changes indicative of activation in the substantia nigra and striatum.
• Microglial activation was observed as early as day 1 and persisted up to day 14 post-intoxication.
• Depletion of dopaminergic neurons was most severe at 7 and 14 days after MPTP treatment, correlating with the timing of microglial activation.

Conclusions:

• Microglial activation is an early event in the MPTP-induced mouse model of Parkinson's disease.
• The findings suggest that microglial activation may contribute to the cascade of pathological events leading to dopaminergic neurodegeneration in PD.